Deng Ning
Partner @ Dingxin Capital
Deng Ning is a seed investor at Dingxin Capital focused on Therapeutics and Medical. Deng Ning is the partner of Dingxin Capital.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 25%
Last updated:
For AI agents: llms.txt
Industries Deng Ning invests in
Stages Deng Ning invests in
Countries Deng Ning invests in
Investment Focus
Industry
- Therapeutics 3 (75%)
- Medical 2 (50%)
- Health Care 2 (50%)
- Medical Device 2 (50%)
- Pharmaceutical 2 (50%)
Stage
- Seed 2 (50%)
- Series B 1 (25%)
- Series D 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Xingaotopi
|
Xingaotopi focuses on the innovative development of novel therapeutic drugs for sensorineural hearing loss, aiming to restore auditory function and improve quality of life through advanced biomedical research and cutting-edge treatment technologies. | $14.3M / Seed / Jan 04, 2026 | |
Reju Therapeutics
|
Reju Therapeutics, a biopharmaceutical company, is dedicated to research and development of drugs for treating degenerative diseases like neurodegenerative, fibrotic, and inflammatory conditions. | Seed / May 08, 2024 | |
Brattea
|
Brattea is a medical device research and development company. Brattea focuses on the development and commercialization of renal denervation products with indications in hypertension, cancer pain and diabetes. | Series D / Mar 25, 2024 | |
Ruining Bio
|
Ruining Bio provides clinical medical solutions such as tumor radiotherapy protection, wound repair, tumor embolization, and anti-tumor drugs. Ruining Bio brings together various professionals in materials, chemistry, biomedical engineering, and clinical medicine. | $8.5M / Series B / Jan 24, 2024 |
Co-Investors
About Dingxin Capital
Dingxin Capital is an investment management agency that specializes in equity investments. The partners are mainly from domestic first-line investment institutions such as CDH, Jiuding and Zhongjin. They have deep accumulation and rich experience in the equity investment field, paying attention to the construction of the whole organization andtrying to build a truly sustainable competition. Investment institutions.
Dingxin Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Deng Ning
Partner
|
|||
|
Hu Hui
Founding partner
|
|||
Yu Kang
Senior Investment Manager
|
|||
|
Zhou Zhou
Senior Partner
|
|||
1 more contact available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Deng Ning invest in?
Deng Ning invests primarily in Therapeutics, Medical and Health Care startups, most often at Seed and Series B stage. Most of the 4 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Deng Ning last invest?
The most recent investment recorded for Deng Ning closed in Jan 2026. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
